Osaka Medical and Pharmaceutical University · Graduate School of Pharmaceutical Sciences / Department of Pharmacy / Faculty of Pharmaceutical Sciences · 教授

Research keywordsFXR modulator chemistry・nuclear receptor pharmacology・PI3K Akt signaling・tuft cell pathology・lipid metabolism control

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Limonoid 7-Deacetoxy-7-Oxogedunin (CG-1) Attenuates RANKL-Induced Osteoclastogenesis via Inhibiting PI3K/Akt-NFATc1 Axis2026 · Cells / MDPI AG / 15 / 10
• A Review on Farnesoid X Receptor (FXR) Modulators Focusing on Benzimidazole Scaffold2026 · Molecules / MDPI AG / 31 / 3
• Antioxidant Activity of Flavonoid Glabranin by Upregulating Antioxidant Gene Expression via MEK/ERK and PI3K/Akt Pathways in Human Neuroblastoma SH-SY5Y Cells2026 · Neurochemical Research / Springer Science and Business Media LLC / 51 / 3
• Presence of tuft cells expressing haematopoietic prostaglandin D synthase in intraductal papillary mucinous neoplasms of the pancreas2026 · Molecular and Clinical Oncology / Spandidos Publications / 25 / 1

• Genetic and pharmacological inhibition of lipocalin-type prostaglandin D synthase suppresses obesity2026
• 異所性脂肪蓄積とインスリン抵抗性におけるプロスタグランジンD2の機能と制御機構解明2024
• エイコサノイドとその代謝物による肥満制御機構の解明2020
• CAR-T療法と微小環境標的内用放射線療法の融合によるがん治療革新研究2019

• Official profile